🌟 Exciting Milestone at BCN Peptides! 🌟
🚀 BCN Peptides has recently launched the RETISOM Clinical Trial, aimed at patients with moderate-severe Diabetic Retinopathy. The study has been activated across 8 renowned opthalmological centers: ICR, VHIR, IOA, St Pau, IMO, IOFV, C. Baviera and IOBA
👁️ Study Objective: To evaluate the efficacy of a non-invasive solution based on eyedrops, to control disease progression before serious complications such as edema, neovascularization, and retinal hemorrhage occur.
💡 Interested in more details or participating? Visit our study site (REec Identifier: 2023-505791-30-01) or contact our team at ctinfodesk@bcnpeptides.com
🤝 Collaborations and progress are key to addressing challenges in eye care. Join us on this journey towards innovation!
#RETISOM #DiabeticRetinopathy #Innovation #Eyecare #Vision #Advancedtherapies
We are thrilled to announce our participation in CPHI China 2024! One of the premier events in the pharmaceutical industry, taking place in Shanghai!
📅 Date: 19th to 21st June 2024
📍 Location: Shanghai, China
🏢 Booth: E1Q03
Our Sales Area Manager, Stephanie Wang, will be on-site to showcase our innovative peptide solutions and discuss how BCN Peptides can support your pharmaceutical and biotechnological needs.
We are committed to excellence in peptide synthesis and development, delivering high-quality, customised products that meet the unique demands of our clients. Whether you’re interested in our new Peptide-based Personalised Neoantigen Medicine, or other cutting-edge offerings, Stephanie will be there to help.
Don’t miss the opportunity to connect with us at CPHI China 2024! Visit our booth E1Q03 and explore how BCN Peptides can be your partner in driving forward your research and development projects.
See you in Shanghai! ✨
hashtag#BCNPeptides hashtag#CPhIChina2024 hashtag#Pharmaceuticals hashtag#Biotechnology hashtag#Innovation hashtag#PeptideTherapeutics
Join us at this premier event to explore the latest innovations in biotechnology and peptide therapeutics.
📅 Date: 3 – 6 June 2024
📍 Location: San Diego, CA
Our Sales Area Manager, Dr. Marina Pascual, and Business Development Manager, Dr. Helena Sabata, will be there to showcase our cutting-edge solutions and discuss how BCN Peptides can support your research and development needs.
At BCN Peptides, we’re dedicated to pushing the boundaries of science and delivering high-quality, customized peptide products and services. Whether you’re interested in our new Chemical Entities Service or our Peptide-based Personalised Neoantigen Medicine, Marina and Helena will be there to help.
Don’t miss this opportunity to connect with us at BIO 2024! Meet Helena and Marina, and learn how BCN Peptides can partner with you to drive your projects forward.
See you in San Diego!
#BCNPeptides #BIO2024 #Biotechnology #Innovation #PeptideTherapeutics
Join us at TIDES USA 2024 from 14th to 17th of May, the premier event for oligonucleotide and peptide therapeutics, taking place in Boston next week!
Discover the latest advancements in peptide-based therapies and personalized medicine. Our team, led by our Sales Director, Dr. Jordi Piró, and Sales Area Manager, Dr. Marina Pascual, will be on hand to showcase our cutting-edge solutions and discuss how BCN Peptides can partner with you to advance your research and development goals.
Don’t miss this opportunity to connect with BCN Peptides at TIDES USA 2024!
Visit our booth #814 and meet Marina and Jordi to discover how we can collaborate to shape the future of biotechnology together.
See you in Boston!
